Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608764 · ClinicalTrials.gov registry record
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial of Pulmonary Disease, Chronic Obstructive and Emphysema, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 10,718
- Enrollment target
- 20
- Study locations
NCT00608764: Active study of Pulmonary Disease, Chronic Obstructive and Emphysema, sponsored by Brigham and Women's Hospital.
NCT00608764 is a study of Pulmonary Disease, Chronic Obstructive and Emphysema that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 10,718 participants, above the 899-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (1092% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608764, a study of Pulmonary Disease, Chronic Obstructive and Emphysema, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 10,718 participants
- Enrollment target
- 20
- Study locations
Study Summary
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.
Conditions Studied
Study Locations (20)
Minnesota
- Minneapolis VA Medical Center - Minneapolis
- HealthPartners Research Foundation - Minneapolis
- University of Minnesota - Minneapolis
California
- University of California at San Diego - San Diego
- Los Angeles Biomedical Research Institute - Torrance
Massachusetts
- Brigham and Women's Hospital - Boston
- Reliant Medical Group - Worcester
Michigan
- Ann Arbor VA Medical Center - Ann Arbor
- University of Michigan - Ann Arbor
Pennsylvania
- Temple University - Philadelphia
- University of Pittsburgh - Pittsburgh
Texas
- Baylor College of Medicine - Houston
- University of Texas Health Sciences Center at San Antonio - San Antonio
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,718 participants |
| Start Date | 2007-11 |
| Est. Completion | 2028-08 |
What the registry record for NCT00608764 still lists
NCT00608764 is an observational study that tracks outcomes without assigning an intervention. Its 10,718 participants enrollment target places it among the larger protocols in the corpus, above the 899-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (1092% higher).
The record links to 3 conditions, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 0 interventions.
NCT00608764 names 20 study sites across 13 states, led by Minnesota, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00608764 about?
NCT00608764 is a clinical study titled "Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)". Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.
What is the current status of trial NCT00608764?
This trial is currently active not recruiting. The enrollment target is 10,718 participants. The study started on 2007-11. Estimated completion is 2028-08.
What conditions does trial NCT00608764 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive, Emphysema, Bronchitis, Chronic.
Who is sponsoring clinical trial NCT00608764?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608764 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00608764's enrollment target sits among peer trials
10,718 1st of 74 higher than 74 of 74 other Pulmonary Disease, Chronic Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Disease, Chronic Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RECRUITING · Phase 3
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 1
-
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
RECRUITING · NA
-
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RECRUITING · Phase 3
-
Trial to Determine Effective Aspirin Dose in COPD
RECRUITING · Phase 3
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia